{
    "Trade/Device Name(s)": [
        "TDM Control Set"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K070200",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060429"
    ],
    "Regulatory Class": "Class I (reserved)",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "March 19, 2007",
    "Summary Letter Received Date": "March 7, 2007",
    "Submission Date": "March 6, 2007",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology"
    ],
    "Analyte(s)": [
        "Acetaminophen",
        "Amikacin",
        "Carbamazepine",
        "Digoxin",
        "Gentamicin",
        "Lidocaine",
        "N-acetylprocainamide",
        "Phenobarbital",
        "Phenytoin",
        "Primidone",
        "Procainamide",
        "Quinidine",
        "Salicylate",
        "Theophylline",
        "Tobramycin",
        "Valproic acid",
        "Vancomycin",
        "Serum Barbiturates"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi analyzers",
        "COBAS INTEGRA analyzers"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Diagnostics TDM Control Set, a serum-based quality control material containing 17 therapeutic drugs for use on Roche/Hitachi and COBAS INTEGRA analyzers.",
    "Indications for Use Summary": "Intended for use as an assayed quality control product on Roche/Hitachi and COBAS INTEGRA analyzers for monitoring therapeutic drug levels including serum barbiturates and 17 specified drugs.",
    "fda_folder": "Clinical Chemistry"
}